Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

Determination of the Optimal Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03176745
• Other study ID #: MBW-number
• Status: Completed
• Phase: N/A
• First received: June 2, 2017
• Last updated: June 2, 2017
• Start date: July 1, 2015
• Est. completion date: January 15, 2017

Study information

• Verified date: June 2017
• Source: Universitätsmedizin Mannheim
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators aim to determine the optimal number of measurements required for multiple-breath-washout derived lung function parameters in adults with pulmonary disease as well as in healthy controls

Recruitment information / eligibility

• Status: Completed
• Enrollment: 153
• Est. completion date: January 15, 2017
• Est. primary completion date: June 30, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion criteria:

• informed consent

Exclusion Criteria:

• inability to perform multiple breath washout testing

Related Conditions & MeSH terms

• Asthma
• Bronchial Asthma
• Chronic Obstructive Pulmonary Disease
• Healthy Controls
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive
• Sarcoidosis

Intervention

Diagnostic Test:
• multiple breath washout
determination of lung clearance index using SF6 multiple breath washout

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Universitätsmedizin Mannheim

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change of lung clearance index (LCI) as determined by multiple breath washout	comparing the repeatability of duplicate vs. triplicate LCI measurements	60 minutes